Daily Low-Dose Aspirin May Reduce Risk of Some Cancers

This article originally appeared here.
Share this content:
Daily Low-Dose Aspirin May Reduce Risk of Some Cancers
Daily Low-Dose Aspirin May Reduce Risk of Some Cancers

(HealthDay News) -- Taking low-dose aspirin every day may lower the overall risk of cancer by 3 percent, mostly due to larger reductions seen in risk for colon and gastrointestinal tumors, according to research published online March 3 in JAMA Oncology.

Andrew Chan, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues looked at the link between aspirin and cancer among 135,965 women and men who took part in the long-term Nurses' Health Study and the Health Professionals Follow-up Study. During more than 30 years of follow-up, there were 20,414 cancers among 88,084 women and 7,571 cancers among 47,881 men.

Continue Reading Below

Taking low-dose aspirin two times or more per week was associated with a 3 percent lower risk for cancer overall, mostly due to a 15 percent lower risk for gastrointestinal cancers and a 19 percent lower risk for cancers of the colon and rectum. The benefit was only seen after six years of taking aspirin almost daily, the researchers found. Aspirin was not associated with a lower risk for other major cancers, such as breast, prostate, or lung cancer.

"There is scientific evidence that aspirin has an effect on certain biological pathways that can result in cancer," Chan told HealthDay. And it also reduces inflammation and the amount of some cancer-causing proteins. "The evidence has reached the point that it may be useful to consider using aspirin to prevent colon cancer," Chan said. "But we are still not at a point where the general population should take aspirin for cancer prevention."

One author disclosed financial ties to Bayer Healthcare, Pfizer, and Pozen.

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs